240 related articles for article (PubMed ID: 24390756)
1. New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.
Chighizola CB; Gerosa M; Meroni PL
Curr Rheumatol Rep; 2014 Feb; 16(2):402. PubMed ID: 24390756
[TBL] [Abstract][Full Text] [Related]
2. Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools.
Meroni PL
Lupus; 2016 Jul; 25(8):905-10. PubMed ID: 27252268
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
[TBL] [Abstract][Full Text] [Related]
4. The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome.
Yin D; de Laat B; Devreese KMJ; Kelchtermans H
Autoimmun Rev; 2018 Dec; 17(12):1210-1218. PubMed ID: 30316989
[TBL] [Abstract][Full Text] [Related]
5. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.
Chighizola CB; Pregnolato F; Andreoli L; Bodio C; Cesana L; Comerio C; Gerosa M; Grossi C; Kumar R; Lazzaroni MG; Mahler M; Mattia E; Nalli C; Norman GL; Raimondo MG; Ruffatti A; Tonello M; Trespidi L; Tincani A; Borghi MO; Meroni PL
J Autoimmun; 2018 Jun; 90():76-83. PubMed ID: 29454510
[TBL] [Abstract][Full Text] [Related]
6. Domain I: the hidden face of antiphospholipid syndrome.
Pericleous C; Rahman A
Lupus; 2014 Oct; 23(12):1320-3. PubMed ID: 25228738
[TBL] [Abstract][Full Text] [Related]
7. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
[TBL] [Abstract][Full Text] [Related]
8. The future of antiphospholipid antibody testing.
de Groot PG; Urbanus RT
Semin Thromb Hemost; 2012 Jun; 38(4):412-20. PubMed ID: 22618531
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.
Roggenbuck D; Borghi MO; Somma V; Büttner T; Schierack P; Hanack K; Grossi C; Bodio C; Macor P; von Landenberg P; Boccellato F; Mahler M; Meroni PL
Arthritis Res Ther; 2016 May; 18(1):111. PubMed ID: 27209064
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
12. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study.
Yin D; Chayoua W; Kelchtermans H; de Groot PG; Moore GW; Gris JC; Zuily S; Musial J; de Laat B; Devreese KMJ
J Thromb Haemost; 2020 Feb; 18(2):463-478. PubMed ID: 31749277
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
Raimondo MG; Pericleous C; Radziszewska A; Borghi MO; Pierangeli S; Meroni PL; Giles I; Rahman A; Ioannou Y
PLoS One; 2017; 12(10):e0186513. PubMed ID: 29049363
[TBL] [Abstract][Full Text] [Related]
17. Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.
Shovman O; Gilburd B; Barzilai O; Langevitz P; Shoenfeld Y
Clin Rev Allergy Immunol; 2007 Apr; 32(2):145-52. PubMed ID: 17916984
[TBL] [Abstract][Full Text] [Related]
18. New autoantigens in the antiphospholipid syndrome.
Alessandri C; Conti F; Pendolino M; Mancini R; Valesini G
Autoimmun Rev; 2011 Aug; 10(10):609-16. PubMed ID: 21545849
[TBL] [Abstract][Full Text] [Related]
19. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome.
Krause I; Blank M; Cervera R; Font J; Matthias T; Pfeiffer S; Wies I; Fraser A; Shoenfeld Y
Ann N Y Acad Sci; 2007 Jun; 1108():481-8. PubMed ID: 17894013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
